Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerance of SMOFlipid 20% in Long-term Parenteral Nutrition
NCT00451646Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- Lipid-based Nanoparticles
- Countries
- 7
01
Overview
A Phase 3 trial of SMOFlipid in Malnutrition, sponsored by Fresenius Kabi. Started Oct 2007; status: completed.
02
Drugs
SMOFlipid
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT00451646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451646.